[HTML][HTML] Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct
…, A Aghaebrahim, JM Olivot, WG Tekle… - … England Journal of …, 2018 - Mass Medical Soc
Background The effect of endovascular thrombectomy that is performed more than 6 hours
after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is …
after the onset of ischemic stroke is uncertain. Patients with a clinical deficit that is …
Early experience utilizing artificial intelligence shows significant reduction in transfer times and length of stay in a hub and spoke model
…, RR Rabah, L Preston, WG Tekle… - Interventional …, 2020 - journals.sagepub.com
Background Recently approved artificial intelligence (AI) software utilizes AI powered large
vessel occlusion (LVO) detection technology which automatically identifies suspected LVO …
vessel occlusion (LVO) detection technology which automatically identifies suspected LVO …
National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era
Background and Purpose— Because several new devices for mechanical thrombectomy have
become available, the outcomes of patients undergoing endovascular treatment for acute …
become available, the outcomes of patients undergoing endovascular treatment for acute …
Direct to angiography vs repeated imaging approaches in transferred patients undergoing endovascular thrombectomy
…, L Elijovich, M Dannenbaum, O Mir, WG Tekle… - JAMA …, 2021 - jamanetwork.com
Importance A direct to angiography (DTA) treatment paradigm without repeated imaging for
transferred patients with large vessel occlusion (LVO) may reduce time to endovascular …
transferred patients with large vessel occlusion (LVO) may reduce time to endovascular …
The Society of Vascular and Interventional Neurology (SVIN) mechanical thrombectomy registry: methods and primary results
…, AK Starosciak, AE Hassan, WG Tekle… - Stroke: Vascular and …, 2022 - Am Heart Assoc
Background A better understanding of real‐world practice patterns in the endovascular
treatment for large vessel occlusion acute ischemic stroke is needed. Here, we report the …
treatment for large vessel occlusion acute ischemic stroke is needed. Here, we report the …
Drip-and-ship thrombolytic treatment paradigm among acute ischemic stroke patients in the United States
Background and Purpose— To provide a national assessment of thrombolytic administration
using drip-and-ship treatment paradigm. Methods— Patients treated with the drip-and-ship …
using drip-and-ship treatment paradigm. Methods— Patients treated with the drip-and-ship …
Mediation of Successful Reperfusion Effect through Infarct Growth and Cerebral Edema: A Pooled, Patient‐level Analysis of EXTEND‐IA Trials and SELECT …
…, T Kleinig, D Shah, TY Wu, WG Tekle… - Annals of …, 2023 - Wiley Online Library
Objective Reperfusion therapy is highly beneficial for ischemic stroke. Reduction in both infarct
growth and edema are plausible mediators of clinical benefit with reperfusion. We aimed …
growth and edema are plausible mediators of clinical benefit with reperfusion. We aimed …
Clinical and neuroimaging outcomes of direct thrombectomy vs bridging therapy in large vessel occlusion: analysis of the SELECT cohort study
…, R Budzik, N Vora, A Arora, B Alenzi, WG Tekle… - Neurology, 2021 - AAN Enterprises
Objective To evaluate the comparative safety and efficacy of direct endovascular thrombectomy
(dEVT) compared to bridging therapy (BT; IV tissue plasminogen activator + EVT) and to …
(dEVT) compared to bridging therapy (BT; IV tissue plasminogen activator + EVT) and to …
Thirty-day outcomes of resolute onyx stent for symptomatic intracranial stenosis: a multicenter propensity score–matched comparison with stenting versus aggressive …
…, RS Nunna, JM Beall, I Khan, M Khan, WG Tekle… - …, 2023 - journals.lww.com
BACKGROUND: Symptomatic intracranial atherosclerotic disease (sICAD) is estimated to
cause 10% of strokes annually in the United States. However, treatment remains a challenge …
cause 10% of strokes annually in the United States. However, treatment remains a challenge …
Factors associated with favorable response to hyperbaric oxygen therapy among patients presenting with iatrogenic cerebral arterial gas embolism
WG Tekle, CD Adkinson, SA Chaudhry, V Jadhav… - Neurocritical care, 2013 - Springer
Background Iatrogenic cerebral arterial gas embolism (CAGE) is an uncommon but potentially
a fatal condition. Hyperbaric oxygen (HBO 2 ) therapy is the only definitive treatment for …
a fatal condition. Hyperbaric oxygen (HBO 2 ) therapy is the only definitive treatment for …
